Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data

BackgroundMeta-analysis handles randomized trials with no outcome events in both treatment and control arms inconsistently, including them when risk difference (RD) is the effect measure but excluding them when relative risk (RR) or odds ratio (OR) are used. This study examined the influence of such trials on pooled treatment effects.MethodsAnalysis with and without zero total event trials of three illustrative published meta-analyses with a range of proportions of zero total event trials, treatment effects, and heterogeneity using inverse variance weighting and random effects that incorporates between-study heterogeneity.ResultsIncluding zero total event trials in meta-analyses moves the pooled estimate of treatment effect closer to nil, decreases its confidence interval and decreases between-study heterogeneity. For RR and OR, inclusion of such trials causes small changes, even when they comprise the large majority of included trials. For RD, the changes are more substantial, and in extreme cases can eliminate a statistically significant effect estimate.ConclusionTo include all relevant data regardless of effect measure chosen, reviewers should also include zero total event trials when calculating pooled estimates using OR and RR.

[1]  Jonathan J Deeks,et al.  Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events , 2007, Statistics in medicine.

[2]  George Davey Smith,et al.  Meta-analysis: Principles and procedures , 1997, BMJ.

[3]  P. Glasziou,et al.  Antibiotics for sore throat. , 2004, The Cochrane database of systematic reviews.

[4]  P. Glasziou,et al.  Antibiotics for sore throat. , 2013, Nursing times.

[5]  H. Handoll,et al.  Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. , 2002, The Cochrane database of systematic reviews.

[6]  D. Cook,et al.  Stress ulcer prophylaxis in the critically ill: a meta-analysis. , 1991, The American journal of medicine.

[7]  E. Bow,et al.  Antifungal prophylaxis for severely neutropenic chemotherapy recipients , 2002, Cancer.

[8]  P. Glasziou,et al.  Antibiotics for sore throat (Review) , 2006 .

[9]  Alexander J Sutton,et al.  What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. , 2004, Statistics in medicine.

[10]  J. L. Tang,et al.  Weighting bias in meta-analysis of binary outcomes. , 2000, Journal of clinical epidemiology.

[11]  A. Ohlsson,et al.  Antibiotics for sore throat to prevent rheumatic fever: Yes or No? How the Cochrane Library can help , 2004, Canadian Medical Association Journal.

[12]  A Whitehead,et al.  A general parametric approach to the meta-analysis of randomized clinical trials. , 1991, Statistics in medicine.

[13]  Lisa A. Weissfeld,et al.  An assessment of the use of the continuity correction for sparse data in meta-analysis , 1996 .

[14]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[15]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[16]  Joseph Beyene,et al.  Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death , 2005, Annals of Internal Medicine.